A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/36 (2006.01) A61K 38/48 (2006.01) A61P 7/04 (2006.01)
Patent
CA 2437024
The combination of recombinant factor VIIa and fibrinogen is effective in treatment for bleeding where direct pressure, tourniquets, indirect pressure, surgical ligation, bandaging, and transfusion of blood or plasma products are typically used. The combination of factor VIIa and fibrinogen is administered intravenously, either sequentially or simultaneously. The compositions may be safely circulated in the blood vessels to sites of injury. This is effective for single or multiple external or internal wounds.
Selon l'invention, l'association du facteur combinant VIIa et du fibrinogène permet de traiter les saignements dans les cas où l'on avait généralement recours à la pression directe, aux tourniquets, à la pression indirecte, à la ligature chirurgicale, aux bandages et à la transfusion de produits sanguins ou plasmatiques. L'association du facteur VIIa et du fibrinogène est administrée par voie intraveineuse, de manière séquentielle ou simultanée. Ces compositions peuvent circuler librement dans les vaisseaux sanguins vers les sites de blessure. Ce produit est efficace pour une simple blessure ou de multiples blessures externes ou internes.
Smart & Biggar
The Government Of The United States As Represented By The Secretary Of The Army
LandOfFree
Compositions for treatment of hemorrhaging with activated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for treatment of hemorrhaging with activated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for treatment of hemorrhaging with activated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2037479